Sunday, 14 July 2024


ResApp announces positive results for new novel smartphone-based COVID-19 screening test

28 March 2022 | News

92% sensitivity for detecting COVID-19 with a new cough audio-based algorithm – exceeding the real-world measured sensitivity of rapid antigen testing

Image credit: shutterstock

Image credit: shutterstock

ResApp Health, a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, has announced positive results for a new novel cough audio-based COVID-19 screening test that only requires a smartphone. In a pilot clinical trial of 741 patients (446 COVID-19 positive) recruited in the United States and India, ResApp’s screening test, which uses machine learning to analyse the sound of a patient’s cough, was found to correctly detect COVID-19 in 92% of people with the infection.

ResApp’s algorithm achieved an area under the curve (AUC) of 0.93 using cough audio and patient-reported symptoms across both trials. AUC is a standard measure of how well a test distinguishes between two diagnostic groups, where a value of 1 represents a perfect test. A value greater than 0.9 is considered outstanding.

With this AUC, ResApp can select different operating points depending on the setting to achieve either high sensitivity, high specificity, or a balanced sensitivity and specificity. For use as a screening test prior to a rapid antigen or polymerase chain reaction (PCR) test to rule out COVID-19, an operating point that provides a 92% sensitivity and 80% specificity could be selected. This sensitivity exceeds the real-world measured sensitivity of rapid antigen tests. The combination of high sensitivity and 80% specificity results in 8 out of 10 people without COVID-19 being correctly screened as negative and not requiring a follow-on rapid antigen or PCR test.

ResApp will initially target use in settings where frequent COVID-19 testing is required, such as employee, healthcare worker and student screening, travel, sports, entertainment, and aged care. In these settings a high sensitivity test that only requires a smartphone would significantly reduce the number of rapid antigen or PCR tests required, improving availability, reducing costs, and reducing environmental impact. A smartphone-based test also has the ability to improve security and reporting of results using biometric identification such as facial recognition.

 

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account